NEW YORK, Dec. 04, 2018 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP announces that class action lawsuits have
commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead
plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links
provided. There is no cost or obligation to you.
Trevena, Inc. (NASDAQGS: TRVN)
Class Period: May 2, 2016 - October 9, 2018
Lead Plaintiff Deadline: December 10, 2018
Join the action: https://www.zlk.com/pslra-1/trevena-inc-loss-form?wire=3
About the lawsuit: During the class period, Trevena, Inc. allegedly made materially false and/or misleading statements and/or
failed to disclose that: (a) during its meetings with the FDA prior to the start of the Class Period, Trevena had been advised that
the FDA did not agree with certain aspects of the design of the Phase III clinical trial of Olinvo, including the proposed dosing,
the proposed primary endpoint and the proposed non-inferiority margin for comparing morphine to Olinvo; (b) unless Trevena
demonstrated that Olinvo was at least equally effective to morphine in treating post-operative pain in the Phase III clinical
trial, the FDA would be unwilling to consider any secondary benefits Olinvo might confer in terms of reduced opioid-related adverse
effects ("ORAEs"); (c) the FDA disagreed with how the safety data was being compiled in the Phase II clinical trial; (d) because
the FDA did not agree with major tenants of the design of the Phase III clinical trial, it was highly unlikely that the FDA would
find the data obtained from that clinical trial sufficient to support Trevena’s NDA; (e) because the Phase III clinical trial data
being derived would not likely be deemed sufficient to support the NDA for Olinvo, the Company would not be able to market Olinvo
as soon as it was leading the market to expect, if ever; and (f) as a result of the foregoing, the Company was not on track to
achieve the commercial sales revenues from Olinvo as soon as Defendants had led the market to expect during the Class Period, if
ever.
To learn more about the Trevena, Inc. class action contact jlevi@levikorsinsky.com.
Stitch Fix, Inc. (NASDAQ: SFIX)
Class Period: June 8, 2018 - October 1, 2018
Lead Plaintiff Deadline: December 10, 2018
Join the action: https://www.zlk.com/pslra-1/stitch-fix-inc-loss-form?wire=3
About the lawsuit: Throughout the class period, Stitch Fix, Inc. allegedly made materially false and/or misleading statements
and/or failed to disclose that: (1) Stitch Fix’s active client growth had slowed to a crawl; (2) Stitch Fix had completely shut
down its television advertising campaign for 10 of the 13 weeks in fourth quarter 2018, dramatically decreasing the number of new
active client additions; and (3) as a result, the Company’s current business metrics and financial prospects were not as strong as
it had led the market to believe during the Class Period.
To learn more about the Stitch Fix, Inc. class action contact jlevi@levikorsinsky.com.
Dycom Industries, Inc. (NYSE: DY)
Class Period: November 20, 2017 - August 10, 2018
Lead Plaintiff Deadline: December 24, 2018
Join the action: https://www.zlk.com/pslra-1/dycom-industries-inc-loss-form?wire=3
About the lawsuit: During the class period, Dycom Industries, Inc. allegedly made materially false and/or misleading statements
and/or failed to disclose that: (i) Dycom’s large projects were highly dependent on permitting and tactical considerations, (ii)
Dycom was facing great uncertainties related to permitting issues; (iii) said uncertainties would expose Dycom to near-term margin
pressure and absorption issues, and (iv) as a result of the foregoing, Defendants’ statements about Dycom’s business, operations,
and prospects, were false and misleading and/or lacked a reasonable basis.
To learn more about the Dycom Industries, Inc. class action contact jlevi@levikorsinsky.com.
You have until the lead plaintiff deadlines to request the court appoint you as lead plaintiff. Your ability to share in any
recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys
have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of
dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com
